Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

digital pathology companies

Digital Pathology Launched in the ‘Era of COVID-19’

CEO SUMMARY: Is it smart to initiate digital pathology (DP) systems and whole-slide imaging just as a novel coronavirus upends healthcare and society at large? That was the question asked at Poplar Healthcare, a pathology lab in Memphis. Senior management proceeded with the implemen…

Read More



Joint Pathology Center Goes Digital; Signs Deals with Proscia, Huron

IT’S A MAJOR ENDORSEMENT of digital pathology and whole slide imaging. Last week, the federal government’s Joint Pathology Center announced agreements with two digital pathology companies. The goal is to digitize incoming slides and archived slides, support a digital pathol…

Read More



Leica, Aperio, Myriad, AMP, Hologic, Gen-Probe

LEICA BIOSYSTEMS TO ACQUIRE APERIO FOR THE SECOND TIME IN AS MANY YEARS, a global leader in histology systems and products has announced that it will acquire one of the leading digital pathology companies. This time it is Leica Biosystems of Nussloch, German…

Read More



August 10, 2009 “Intelligence: Late Breaking Lab News”

Last week, the pathology profession got a new professional group. It is the Digital Pathology Association (DPA) and it was formed by several companies offering digital pathology systems and services. DPA’s founders say it will support digital pathology education initiatives, define…

Read More



Siemens, BioImagene, Clarient University of Pennsylvania, Mayo Clinic

SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased…

Read More



iTunes Business Model For Digital Path Scans

CEO SUMMARY: If BioImagene’s CEO is to be believed, the company is ready to deliver a digital pathology system that is robust and affordable, even in settings with just two or three pathologists. One key to the BioImagene strategy is “per scan” pricing that avoids the need for upfro…

Read More



;